Valentina Rebecchi

Migraine prodromal symptoms and their clinical manifestations: an observational multicenter study

Marco Bolchini, Matteo Cortinovis, Paola Merlo, Alessandro Viganò et autres

Background: Migraine prodromal symptoms typically emerge 2-48 hours before headache onset and include cognitive, affective, and homeostatic disturbances. Although widely described in the literature, their reported prevalence varies considerably, likely due to methodological differences in symptom assessment. This multicenter observational study aimed …

it, gb (code pays fourni par la source)

Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study

Giorgio Dalla Volta, Antonio Russo, Marcello Silvestro, Raffaele Ornello et autres

BACKGROUND: Migraine with aura (MwA) is a debilitating disorder characterized by paroxysmal attacks of pain preceded or accompanied by reversible neurological symptoms. While the pathophysiology remains unclear, trigeminovascular system activation and cortical spreading depression have been implicated. This study aims to comprehensively …

it, us (code pays fourni par la source)

Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study

Valeria Caponnetto, Antonio Russo, Marcello Silvestro, Alessandro Tessitore et autres

BACKGROUND: Real-world studies on fremanezumab, an anti-calcitonin gene-related peptide monoclonal antibody for migraine prevention, are few and with limited follow-up. OBJECTIVE: We aimed to evaluate the long-term (up to 52 weeks) effectiveness and tolerability of fremanezumab in high-frequency episodic migraine and chronic …

it, lb (code pays fourni par la source)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series

Gaia Fanella, Claudio Baiata, Elisa Candeloro, Gianpaolo Toscano et autres

it (code pays fourni par la source)

Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study

Valentina Rebecchi, Daniela Gallo, Lucia Princiotta Cariddi, Eliana Piantanida et autres

Several studies focused on the role of vitamin D (vitD) in pain chronification. This study focused on vitD level and pain chronification and extension in headache disorders. Eighty patients with primary headache underwent neurological examination, laboratory exams, including serum calcifediol 25(OH)D, and …

it (code pays fourni par la source)

Selegiline reduces daytime sleepiness in patients with Parkinson's disease

Marco Gallazzi, M. Mauri, Maria Laura Ester Bianchi, Giulio Riboldazzi et autres

OBJECTIVES: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that …

it (code pays fourni par la source)

Vitamin D, Chronic Migraine and Extracranial Pain: Is there a Link? Data from an Observational Study.

Valentina Rebecchi, Daniela Gallo, Lucia Princiotta Cariddi, Eliana Piantanida et autres

it, us (code pays fourni par la source)

An Example of a Stroke Unit Reshaping in the Context of a Regional Hub and Spoke System in the COVID-19 Era

Elisa Candeloro, Federico Carimati, Payam Tabaee Damavandi, Lucia Princiotta Cariddi et autres

During the COVID-19 outbreak, the Neurology and Stroke Unit (SU) of the hospital of Varese had to serve as a cerebrovascular hub, meaning that the referral area for the unit doubled. The number of beds in the SU was increased from 4 …

it (code pays fourni par la source)

Author response for "Selegiline reduces daytime sleepiness in patients with Parkinson's disease"

Marco Gallazzi, M. Mauri, Maria Laura Ester Bianchi, Giulio Riboldazzi et autres

AURASTOP ® in the Treatment of Migraine Aura

Volta Giorgio Dalla, Fabio Antonaci, Valentina Rebecchi, Grazia Sances et autres

Pharmacologically controlled withdrawal from medication overuse in chronic migraine does non improve the therapeutic response to long-term onabotulinumtoxin type-a prophylaxis

Valentina Rebecchi, Lucia Princiotta Cariddi, Am Clerici, Federico Carimati et autres

Chronic headaches with medication overuse (MOH): non significant influence of preliminary controller withdrawal programs on the response to Onabotulinumtoxin A prophylaxis.

Valentina Rebecchi, Lucia Princiotta Cariddi, Am Clerici, Andrea Sturchio et autres